AnaptysBio Inc (ANAB)

14.50 -0.50 (-3.33%) USD  |  NASDAQ  |  Dec 20, 16:00
14.54 +0.04 (+0.31%) After-Hours: 20:00
More

AnaptysBio Debt to Equity Ratio: 0.00 for Sept. 30, 2024

Debt to Equity Ratio Chart

View Debt to Equity Ratio for ANAB.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Debt to Equity Ratio Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Debt to Equity Ratio Definition

View Debt to Equity Ratio Definition
Start Trial

The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.

Read full definition.

Debt to Equity Ratio Range, Past 5 Years

View Debt to Equity Ratio Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Debt to Equity Ratio Benchmarks

View Debt to Equity Ratio Benchmarks
Start Trial
Eli Lilly and Co 2.185
SIGA Technologies Inc 0.00
Candel Therapeutics Inc --
NovaBay Pharmaceuticals Inc 0.0476
Palatin Technologies Inc --

Debt to Equity Ratio Related Metrics

Total Assets (Quarterly) 493.42M
Total Liabilities (Quarterly) 409.05M
Shareholders Equity (Quarterly) 84.37M
Current Ratio 10.23